DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.42%649M | -3.92%686M | -1.39%639M | 7.88%2.7B | -1.20%657M | 2.57%679M | 2.73%714M | 35.28%648M | 83.63%2.5B | 47.45%665M |
Operating revenue | -4.41%628M | -4.05%664M | -1.59%618M | 7.71%2.61B | -1.24%636M | 2.18%657M | 2.37%692M | 35.64%628M | 85.05%2.43B | 48.05%644M |
Cost of revenue | -4.88%468M | -7.10%471M | -6.22%452M | 7.96%1.95B | -1.67%471M | 2.50%492M | 7.42%507M | 27.85%482M | 59.30%1.81B | 36.86%479M |
Gross profit | -3.21%181M | 3.86%215M | 12.65%187M | 7.65%746M | 0.00%186M | 2.75%187M | -7.17%207M | 62.75%166M | 205.29%693M | 84.16%186M |
Operating expense | -0.98%101M | 0.00%102M | 3.00%103M | 7.67%435M | 31.00%131M | 0.99%102M | 0.00%102M | -0.99%100M | 3.06%404M | 3.09%100M |
Selling and administrative expenses | -5.56%17M | 12.50%18M | 6.25%17M | 3.17%65M | 0.00%15M | 12.50%18M | 0.00%16M | 0.00%16M | 1.61%63M | 7.14%15M |
-General and administrative expense | -5.56%17M | 12.50%18M | 6.25%17M | 3.17%65M | 0.00%15M | 12.50%18M | 0.00%16M | 0.00%16M | 1.61%63M | 7.14%15M |
Depreciation amortization depletion | -3.08%63M | 0.00%64M | 1.56%65M | 6.69%287M | 44.62%94M | -2.99%65M | -5.88%64M | -7.25%64M | -4.27%269M | -4.41%65M |
-Depreciation and amortization | -3.08%63M | 0.00%64M | 1.56%65M | 6.69%287M | 44.62%94M | -2.99%65M | -5.88%64M | -7.25%64M | -4.27%269M | -4.41%65M |
Other operating expenses | 10.53%21M | -9.09%20M | 5.00%21M | 15.28%83M | 10.00%22M | 5.56%19M | 22.22%22M | 25.00%20M | 46.94%72M | 33.33%20M |
Operating profit | -5.88%80M | 7.62%113M | 27.27%84M | 7.61%311M | -36.05%55M | 4.94%85M | -13.22%105M | 6,500.00%66M | 275.15%289M | 2,050.00%86M |
Net non-operating interest income expense | -12.50%-63M | -25.49%-64M | -24.00%-62M | 8.55%-214M | -5.56%-57M | 1.75%-56M | 16.39%-51M | 19.35%-50M | 8.95%-234M | 12.90%-54M |
Non-operating interest income | -33.33%6M | -50.00%5M | -50.00%5M | 192.31%38M | 12.50%9M | 125.00%9M | 900.00%10M | --10M | 1,200.00%13M | 700.00%8M |
Non-operating interest expense | 6.15%69M | 13.11%69M | 11.67%67M | 2.02%252M | 6.45%66M | 6.56%65M | -1.61%61M | -3.23%60M | -4.26%247M | -1.59%62M |
Other net income (expense) | 2,000.00%42M | 103.05%6M | -57.89%8M | -60.17%47M | 4,360.00%223M | -84.62%2M | -307.37%-197M | 280.00%19M | 521.43%118M | 266.67%5M |
Earnings from equity interest | 1,300.00%28M | -66.67%1M | --0 | -26.67%11M | -77.78%2M | 100.00%2M | -40.00%3M | --4M | 314.29%15M | 1,000.00%9M |
Special income (charges) | --15M | 103.94%8M | -42.86%8M | 357.14%32M | 11,150.00%221M | --0 | -10,050.00%-203M | --14M | 150.00%7M | 0.00%-2M |
-Less:Impairment of capital assets | ---- | -96.55%7M | ---- | 3,300.00%204M | ---- | ---- | --203M | ---- | -33.33%6M | ---- |
-Less:Other special charges | ---15M | ---15M | -900.00%-8M | ---221M | ---- | ---- | ---- | --1M | ---- | ---- |
-Write off | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | --0 | --0 | --0 | 15.38%15M | --0 | --0 | --0 | --15M | 360.00%13M | --0 |
Other non- operating income (expenses) | ---1M | -200.00%-3M | ---- | -95.83%4M | --0 | ---- | -96.74%3M | -80.00%1M | 1,471.43%96M | ---2M |
Income before tax | 90.32%59M | 138.46%55M | -14.29%30M | -16.76%144M | 497.30%221M | -16.22%31M | -192.26%-143M | 162.50%35M | 138.44%173M | 160.66%37M |
Income tax | 2M | -500.00%-12M | -50.00%1M | 38M | 1,550.00%33M | 0 | 200.00%3M | 2M | 0 | -50.00%2M |
Net income | 83.87%57M | 145.89%67M | -12.12%29M | -38.73%106M | 437.14%188M | -22.50%31M | -194.81%-146M | 158.93%33M | 138.27%173M | 153.85%35M |
Net income continuous Operations | 83.87%57M | 145.89%67M | -12.12%29M | -38.73%106M | 437.14%188M | -22.50%31M | -194.81%-146M | 158.93%33M | 138.27%173M | 153.85%35M |
Minority interest income | -25.00%3M | -25.00%3M | 1M | -18.18%9M | 0.00%1M | -20.00%4M | 0.00%4M | 0 | 57.14%11M | -50.00%1M |
Net income attributable to the parent company | 100.00%54M | 142.67%64M | -15.15%28M | -40.12%97M | 450.00%187M | -22.86%27M | -200.00%-150M | 157.89%33M | 135.29%162M | 150.75%34M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 2M | 0 | ||||||||
Net income attributable to common stockholders | 100.00%54M | 142.67%64M | -15.15%28M | -41.36%95M | 444.12%185M | -22.86%27M | -200.00%-150M | 157.89%33M | 135.29%162M | 150.75%34M |
Basic earnings per share | 100.00%0.26 | 144.29%0.31 | -13.33%0.13 | -38.03%0.44 | 493.33%0.89 | -13.33%0.13 | -206.06%-0.7 | 162.50%0.15 | 136.41%0.71 | 153.57%0.15 |
Diluted earnings per share | 100.00%0.26 | 142.86%0.3 | -13.33%0.13 | -38.03%0.44 | 486.67%0.88 | -13.33%0.13 | -206.06%-0.7 | 162.50%0.15 | 136.41%0.71 | 153.57%0.15 |
Dividend per share | 66.67%0.25 | 66.67%0.25 | 66.67%0.25 | 392.86%1.38 | 272.00%0.93 | 1,400.00%0.15 | 1,400.00%0.15 | 1,400.00%0.15 | 0.28 | 0.25 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |